193 related articles for article (PubMed ID: 32394295)
1. Once- versus Twice-Daily Aspirin in Patients at High Risk of Thrombotic Events: Systematic Review and Meta-Analysis.
Mainoli B; Duarte GS; Costa J; Ferreira J; Caldeira D
Am J Cardiovasc Drugs; 2021 Jan; 21(1):63-71. PubMed ID: 32394295
[TBL] [Abstract][Full Text] [Related]
2. Once versus twice daily aspirin after coronary bypass surgery: a randomized trial.
Paikin JS; Hirsh J; Ginsberg JS; Weitz JI; Chan NC; Whitlock RP; Pare G; Eikelboom JW
J Thromb Haemost; 2017 May; 15(5):889-896. PubMed ID: 28267249
[TBL] [Abstract][Full Text] [Related]
3. Platelet function one and three months after coronary bypass surgery in relation to once or twice daily dosing of acetylsalicylic acid.
Ivert T; Dalén M; Ander C; Stålesen R; Näsman P; Lordkipanidzé M; Hjemdahl P
Thromb Res; 2017 Jan; 149():64-69. PubMed ID: 27907814
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet agents and anticoagulants for hypertension.
Lip GY; Felmeden DC
Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
[TBL] [Abstract][Full Text] [Related]
5. Multiple daily doses of acetyl-salicylic acid (ASA) overcome reduced platelet response to once-daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial.
Paikin JS; Hirsh J; Ginsberg JS; Weitz JI; Chan NC; Whitlock RP; Pare G; Johnston M; Eikelboom JW
J Thromb Haemost; 2015 Mar; 13(3):448-56. PubMed ID: 25546465
[TBL] [Abstract][Full Text] [Related]
6. Comparison of nine platelet function tests used to determine responses to different aspirin dosages in people with type 2 diabetes.
Harrison P; Bethel MA; Kennedy I; Dinsdale R; Coleman R; Holman RR
Platelets; 2019; 30(4):521-529. PubMed ID: 29985735
[TBL] [Abstract][Full Text] [Related]
7. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
8. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
[TBL] [Abstract][Full Text] [Related]
9. Patients with Essential Thrombocythemia may be Poor Responders to Enteric-Coated Aspirin, but not to Plain Aspirin.
Scavone M; Rizzo J; Femia EA; Podda GM; Bossi E; Caberlon S; Paroni R; Cattaneo M
Thromb Haemost; 2020 Oct; 120(10):1442-1453. PubMed ID: 32717754
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet therapy and anticoagulation in patients with hypertension.
Griffin G
Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
[TBL] [Abstract][Full Text] [Related]
11. Utility of VerifyNow to assess the immediate pharmacodynamic response of chewed and swallowed aspirin: comparison with aggregometry.
Bliden KP; Kundan P; Kraft D; Parekh R; Singh S; Babu AD; Shah AP; Tantry US; Gurbel PA
Platelets; 2024 Dec; 35(1):2298352. PubMed ID: 38166614
[TBL] [Abstract][Full Text] [Related]
12. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.
Bethel MA; Harrison P; Sourij H; Sun Y; Tucker L; Kennedy I; White S; Hill L; Oulhaj A; Coleman RL; Holman RR
Diabet Med; 2016 Feb; 33(2):224-30. PubMed ID: 26043186
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation.
Patrick J; Dillaha L; Armas D; Sessa WC
Postgrad Med; 2015 Aug; 127(6):573-80. PubMed ID: 25998572
[TBL] [Abstract][Full Text] [Related]
15. Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis.
Larsen ML; Pedersen OH; Hvas AM; Niekerk PBVK; Bønløkke S; Kristensen SD; Grove EL
Platelets; 2019; 30(3):322-328. PubMed ID: 29442537
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia.
Squizzato A; Romualdi E; Passamonti F; Middeldorp S
Cochrane Database Syst Rev; 2013 Apr; (4):CD006503. PubMed ID: 23633335
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
Capodanno D; Patel A; Dharmashankar K; Ferreiro JL; Ueno M; Kodali M; Tomasello SD; Capranzano P; Seecheran N; Darlington A; Tello-Montoliu A; Desai B; Bass TA; Angiolillo DJ
Circ Cardiovasc Interv; 2011 Apr; 4(2):180-7. PubMed ID: 21386092
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus.
Gurbel PA; Bliden KP; Chaudhary R; Patrick J; Liu F; Chen G; McLeod C; Tantry US
Am J Cardiol; 2016 Dec; 118(12):1941-1947. PubMed ID: 27769511
[TBL] [Abstract][Full Text] [Related]
19. Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mg p. o. in ACS (ACUTE).
Zeymer U; Hohlfeld T; Vom Dahl J; Erbel R; Münzel T; Zahn R; Roitenberg A; Breitenstein S; Pap ÁF; Trenk D
Thromb Haemost; 2017 Feb; 117(3):625-635. PubMed ID: 28102427
[TBL] [Abstract][Full Text] [Related]
20. Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin.
Schiff M; Hochberg MC; Oldenhof J; Brune K
Curr Med Res Opin; 2009 Oct; 25(10):2471-7. PubMed ID: 19678751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
